Filing
Spy
Filing
Spy
Home
About
GILD — Gilead Sciences, Inc. - FilingSpy
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
4 holders
Ownership
Activity
Fundamentals
2021 Q2
19 of 52 quarters
Total Value
$1.37B
Total Shares
19.94M
Net Share Change
+7.42M
Activity
2 buying
2 selling
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$1.34B
19.46M
1.5%
ADD
+7.36M
(+60.8%)
Dodge & Cox Stock Fund
$1.34B
19.46M shares
ADD
+7.36M
(+60.8%)
Matrix Asset Advisors
$24.10M
350.0K
3.5%
TRIM
-731
(-0.2%)
Matrix Asset Advisors
$24.10M
350.0K shares
TRIM
-731
(-0.2%)
Bridgewater Associates LP
$8.72M
126.7K
0.1%
ADD
+65.1K
(+105.7%)
Bridgewater Associates LP
$8.72M
126.7K shares
ADD
+65.1K
(+105.7%)
Pzena Investment Management
$305.0K
4.4K
0.0%
TRIM
-5.9K
(-57.1%)
Pzena Investment Management
$305.0K
4.4K shares
TRIM
-5.9K
(-57.1%)